Morgan Stanley’s Biocept, Inc. BIOC Stock Holding History

Morgan Stanley’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	8018
2022 Q3	–	Hold	0	–	–	–	8032
2022 Q2	–	Sell	-63	Closed	-$4K	–	8131
2022 Q1	$4K	Buy	63 +2	+3%	+$157	﹤0.01%	7662
2021 Q4	$6K	Sell	61 -235	-79%	-$27.1K	﹤0.01%	7617
2021 Q3	$35K	Sell	296 -5,635	-95%	-$658K	﹤0.01%	6878
2021 Q2	$745K	Buy	5,931 +5,928	+197,600%	+$802K	﹤0.01%	5253
2021 Q1	$1K	Sell	3 -1,612	-100%	-$293K	﹤0.01%	7415
2020 Q4	$215K	Buy	1,615 +1,612	+53,733%	+$230K	﹤0.01%	5553
2020 Q3	$0	Buy	+3	New	+$606	﹤0.01%	6880
2019 Q2	–	Hold	0	–	–	–	6810
2019 Q1	–	Sell	-13	Closed	-$5.27K	–	6768
2018 Q4	$3K	Buy	+13	New	+$6.53K	﹤0.01%	6387
2018 Q3	–	Hold	0	–	–	–	6859
2017 Q4	–	Sell	-1	Closed	-$12K	–	6699
2017 Q3	$12K	Hold	1	–	–	﹤0.01%	6138
2017 Q2	$14K	Hold	1	–	–	﹤0.01%	6170
2017 Q1	$22K	Buy	+1	New	+$17K	﹤0.01%	6064
2016 Q4	–	Hold	0	–	–	–	6589
2016 Q3	–	Hold	0	–	–	–	6453
2016 Q2	–	Hold	0	–	–	–	6322
2016 Q1	–	Hold	0	–	–	–	6222
2015 Q4	–	Sell	-2	Closed	-$106K	–	6129
2015 Q3	$152K	Hold	2	–	–	﹤0.01%	5225
2015 Q2	$109K	Buy	+2	New	+$154K	﹤0.01%	5541
2015 Q1	–	Hold	0	–	–	–	5981
2014 Q4	–	Hold	0	–	–	–	6448
2014 Q3	–	Hold	0	–	-$2K	–	6693
2014 Q2	–	Hold	0	–	–	–	6399
2014 Q1	–	Hold	0	–	–	–	6356

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Morgan Stanley's BIOC Position: Q4 2022 in Review

Morgan Stanley held its Biocept, Inc. (BIOC) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8018.

Morgan Stanley first reported a position in BIOC in Q2 2015 and has held it in 13 quarters since. The position peaked at $745K in Q2 2021. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

Morgan Stanley held 0 shares of Biocept, Inc. worth $0 as of Q4 2022.
Morgan Stanley left its Biocept, Inc. share count unchanged in Q4 2022.
Biocept, Inc. made up ﹤0.01% of Morgan Stanley's portfolio in Q4 2022, its #8018 holding.
Morgan Stanley first reported a position in Biocept, Inc. in Q2 2015 and has held it in 13 quarters since.
Morgan Stanley's Biocept, Inc. position peaked at $745K in Q2 2021.
25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.